Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center, the Lustgarten Laboratory and…
Read More »cancers
Certain types of light have proven to be an effective, minimally invasive treatment for cancers located on or near the…
Read More »
One evening in 2019, Janice Blanock was scrolling through Facebook when she heard a stranger mention her son in a…
Read More » A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell…
Read More » A new detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides rare but…
Read More »:max_bytes(150000):strip_icc()/GettyImages-1286971245-17b74948c93c44799d23697a5ce10f47.jpg?w=780&resize=780,470&ssl=1 "Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers")
Key Takeaways The Food and Drug Administration approved Geron’s drug Rytelo for those with rare blood cancers who are suffering…
Read More » Bioengineering is revolutionizing cancer research, and Moffitt Cancer Center is at the forefront of this transformative movement. Moffitt is the…
Read More » A Stanford Medicine study of thousands of breast cancers has found that the gene sequences we inherit at conception are…
Read More » An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in…
Read More » St. Jude Children’s Research Hospital scientists have identified specific DNA variants in the non-coding regions of the genome contributing to…
Read More »